Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Viveve Medical, Inc. (VIVE)

0.4168   -0.003 (-0.6%) 11-25 12:54
Open: 0.41 Pre. Close: 0.4193
High: 0.4168 Low: 0.41
Volume: 6,256 Market Cap: 4(M)

Technical analysis

as of: 2022-11-25 2:01:17 PM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 0.62     One year: 0.71
Support: Support1: 0.4    Support2: 0.34
Resistance: Resistance1: 0.53    Resistance2: 0.61
Pivot: 0.47
Moving Average: MA(5): 0.41     MA(20): 0.49
MA(100): 0.67     MA(250): 0.85
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 4.2     %D(3): 4.4
RSI: RSI(14): 25
52-week: High: 1.64  Low: 0.4
Average Vol(K): 3-Month: 21 (K)  10-Days: 34 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ VIVE ] has closed above bottom band by 21.7%. Bollinger Bands are 15.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.42 - 0.42 0.42 - 0.43
Low: 0.4 - 0.41 0.41 - 0.41
Close: 0.42 - 0.42 0.42 - 0.42

Company Description

Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.

Headline News

Wed, 23 Nov 2022
Redefining The Future Of Location-Based Entertainment With HTC VIVE Focus 3 And The Park Playground | ARPost - ARPost

Tue, 22 Nov 2022
Vive Funds Targets Atlanta's Hot Real Estate Investment Market - GlobeNewswire

Tue, 22 Nov 2022
VR Headset Black Friday Deals 2022: Early HTC VIVE, HP Reverb, PlayStation VR, Oculus Quest & More Savings Researched by Spending Lab - PRUnderground

Mon, 21 Nov 2022
HTC Black Friday Sales See Vive Flow & Vive Pro 2 Discounted Across Europe - UploadVR

Sun, 20 Nov 2022
New Vive headset leaked, Qualcomm shows off new chips, Meta’s big bang with Galactica - MIXED Reality News

Tue, 15 Nov 2022
Apparent Leak Reveals New HTC Vive Headset With Slim Modular Design - UploadVR

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 11 (M)
Shares Float 11 (M)
% Held by Insiders 0 (%)
% Held by Institutions 9.3 (%)
Shares Short 55 (K)
Shares Short P.Month 48 (K)

Stock Financials

EPS -2.55
EPS Est Next Qtl -0.42
EPS Est This Year -1.95
EPS Est Next Year -1.39
Book Value (p.s.) 0.1
Profit Margin (%) 0
Operating Margin (%) -309.8
Return on Assets (ttm) -62.2
Return on Equity (ttm) -211
Qtrly Rev. Growth 4.1
Gross Profit (p.s.) 0.05
Sales Per Share 0.63
EBITDA (p.s.) -1.9
Qtrly Earnings Growth 0
Operating Cash Flow -16 (M)
Levered Free Cash Flow -8 (M)

Stock Valuations

PE Ratio -0.17
PEG Ratio -0.1
Price to Book value 3.78
Price to Sales 0.65
Price to Cash Flow -0.28

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date 2020-12-01
Ex-Dividend Date Invalid DateTime.
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.